In early 2026, India’s primary markets continue to witness steady momentum, with investors showing sustained interest in sector-specific growth stories. Healthcare, wellness, and alternative medicine businesses have gained traction, driven by rising consumer preference for preventive healthcare and natural treatment solutions. Ayurveda-focused companies, in particular, are benefiting from increased acceptance both domestically and internationally, supported by government initiatives promoting traditional Indian medicine systems.
Against this backdrop, KRM Ayurveda Ltd. is set to enter the capital markets with its upcoming IPO. Below is a detailed overview of KRM Ayurveda Ltd., its IPO details, financial performance, and industry outlook.
About KRM Ayurveda Ltd.
Incorporated on 3 September 2019, KRM Ayurveda Ltd. operates a network of Ayurvedic hospitals and clinics across multiple cities in India, while also extending its reach internationally through telemedicine consultations and product sales. The company is engaged in the manufacturing and distribution of Ayurvedic medicines, herbal and botanical remedies, supplements, and wellness products.
At present, the company operates six hospitals and five clinics across the country. Its service offerings include:
-
Hospitals
-
Clinics
-
Teleconsultation services
-
KRM Ayurveda products
As of August 31, 2025, KRM Ayurveda Ltd. employed 429 personnel across various operational and clinical departments, supporting both healthcare delivery and manufacturing activities.
KRM Ayurveda Ltd. IPO Details
Through the IPO, KRM Ayurveda Ltd. aims to raise capital primarily to strengthen its telemedicine infrastructure, enhance technology systems, expand human resources, reduce existing borrowings, and meet working capital requirements.
Important IPO Timeline
| Event | Date |
|---|---|
| IPO Open Date | January 19, 2026 |
| IPO Close Date | January 21, 2026 |
| Allotment Date (Tentative) | January 22, 2026 |
| Initiation of Refunds | January 23, 2026 |
| Credit of Shares to Demat | January 23, 2026 |
| Listing Date (Tentative) | January 27, 2026 |
Key IPO Details
| Particulars | Details |
|---|---|
| Face Value | ₹10 per share |
| Issue Price Band | ₹128 to ₹135 per share |
| Lot Size | 1,000 shares |
| Total Issue Size | 57,40,000 shares (₹77 Cr approx.) |
| Fresh Issue | 57,40,000 shares |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Shareholding Pre-Issue | 1,55,20,800 shares |
Lot Size of KRM Ayurveda IPO
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 2,000 | ₹2,70,000 |
| Retail (Max) | 2 | 2,000 | ₹2,70,000 |
| S-HNI (Min) | 3 | 3,000 | ₹4,05,000 |
| S-HNI (Max) | 7 | 7,000 | ₹9,45,000 |
| B-HNI (Min) | 8 | 8,000 | ₹10,80,000 |
KRM Ayurveda Ltd. Financials
The KRM Ayurveda IPO carries a pre-issue market capitalisation of ₹287.02 crore. The company has demonstrated strong financial growth, with revenue increasing by 14% and Profit After Tax rising by 255% between FY24 and FY25.
As of March 31, 2025, the company reported robust profitability metrics, including a Return on Equity (ROE) of 67.86% and a Return on Capital Employed (ROCE) of 43.33%, reflecting efficient capital utilisation and improving operational performance.
Key Company Financials
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets (₹ Cr) | 66.79 | 43.91 | 39.48 |
| Total Income (₹ Cr) | 76.95 | 67.57 | 89.38 |
| Profit After Tax (₹ Cr) | 12.10 | 3.41 | 7.60 |
| Net Worth (₹ Cr) | 23.88 | 11.78 | 8.37 |
| Reserves & Surplus (₹ Cr) | 23.73 | 11.63 | 8.22 |
| Total Borrowing (₹ Cr) | 31.20 | 23.18 | 19.87 |
Key Performance Indicators (KPIs)
| KPI | Value (Mar 31, 2025) |
|---|---|
| ROE | 67.86% |
| ROCE | 43.33% |
| Debt-Equity Ratio | 1.31 |
| RoNW | 67.86% |
| PAT Margin | 15.80% |
| EBITDA Margin | 24.96% |
| Price to Book Value | 0.08 |
IPO Objects of the Issue
| Purpose | Estimated Amount (₹ Cr) |
|---|---|
| Telemedicine infrastructure development | 13.67 |
| CRM software & hardware infrastructure | 1.42 |
| Human resources expansion | 5.44 |
| Loan repayment / prepayment | 12.50 |
| Working capital requirements | 18.00 |
| General corporate purposes | Balance |
IPO Valuation Snapshot
| Metric | Pre-IPO | Post-IPO |
|---|---|---|
| EPS (₹) | 7.79 | 5.69 |
| P/E (x) | 17.32 | 23.73 |
| Promoter Holding | 92.15% | — |
| Market Capitalisation | ₹287.02 Cr | — |
KRM Ayurveda Ltd.: Industry Outlook
-
Rising consumer inclination toward natural and preventive healthcare is boosting demand for Ayurvedic treatments and wellness services.
-
Government support through AYUSH initiatives continues to promote traditional medicine systems in India.
-
Growth in telemedicine adoption is expanding healthcare access, especially for alternative medicine providers.
-
Increasing global awareness of herbal and botanical remedies supports export potential for Ayurvedic products.
-
Integrated healthcare models combining treatment, consultation, and product sales offer scalable revenue streams.
Conclusion
KRM Ayurveda Ltd. presents an interesting investment opportunity within India’s expanding Ayurveda and alternative healthcare segment. The company benefits from a growing hospital and clinic network, improving financial performance, and increasing demand for holistic wellness solutions. However, investors should carefully evaluate factors such as regulatory dependencies, scalability of healthcare operations, and competitive intensity within the broader healthcare sector before making an investment decision.
